Stay updated with breaking news from Hpcsa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Five doctors who failed to adequately treat a Newcastle cancer patient at Grey's Hospital in Pietermaritzburg have been found guilty of unprofessional conduct after the tumour on his face could have been removed before becoming a death sentence.
Walter Sisulu University has been offering a programme, described as "useless" by past graduates, and slated by health academics for its lack of utility, without the required professional recognition for 10 years. The university's Bachelor of Science in Health Promotion is not registered by the Health Professions Council of South Africa (HPCSA) and a senior university employee who asked not to be named confirmed that “thousands” of students were affected.
Equities analysts predict that Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) will report earnings of ($0.24) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings per share of ($0.14) during the same quarter last year, which suggests a negative year […]
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 79,600 shares, a decrease of 21.2% from the March 15th total of 101,000 shares. Currently, 0.7% of the shares of the company are sold short. Based on […]
Zacks Investment Research upgraded shares of Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) from a sell rating to a hold rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who […]